Methodologic issues in assessing the quality of life of cancer patients

Cancer

Volumn 67, Issue 3 S, 1991, Pages 844-850

  Aaronson, Neil K ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CONFERENCE PAPER; HUMAN; METHODOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE;

FAMILY; HUMAN; METHODS; NEOPLASMS; PHYSICIAN'S ROLE; QUALITY OF LIFE; RESEARCH DESIGN;

EID: 0026012063     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19910201)67:3+<844::AID-CNCR2820671416>3.0.CO;2-B     Document Type: Article

References (64)

1. Quality of life after breast cancer surgery
2. The effect of radical and conserving surgery on the quality of life of early breast cancer patients
3. Depression and body image following mastectomy and lumpectomy
4. Psychosocial outcome in a randomized surgical trial for treatment of primary breast cancer
5. Improving the quality of life during chemotherapy for advanced breast cancer
6. A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer
7. Quality of life assessment of patients in extremity sarcoma clinical trials
8. Measuring the quality of life in cancer clinical trials: A sample survey of published trials
9. Quality of life variables in surgical trials
10. Clinical evaluation of chemotherapeutic agents in cancer
11. Cancer—appraisal of methods for the study of chemotherapy of cancer in man: Thiophosphoramide
12. Who should measure quality of life, the doctor or the patient?
13. Scientific problems in clinical scales as demonstrated by the Karnofsky index of performance status
14. Karnofsky performance status revisited: Reliability, validity and guidelines
15. Investigations of the Karnofsky performance status as a measure of quality of life
16. The Karnofsky performance status scale: An examination of its reliability and validity in a research setting
17. The psychological impact of cancer and cancer surgery: I. Adaption to the dry colostomy; preliminary report and summary findings
18. Significant others and self between perceived and actual evaluations
19. Consensual validation of personality traits: Evidence from self‐reports and ratings
20. The use of next‐of‐kin to estimate pain in cancer patients
21. Development of a questionnaire measure of adjustment to cancer: The MAC scale
22. Using proxies to evaluate quality of life
23. An investigation of the response of the spouse to chronic pain behavior
24. Living with chronic pain: The spouse's perspective
25. The use of female spouse proxies in common symptom reporting
26. The treatment of disease and the war against cancer
27. Clinimetric perspectives
28. Assessment of the quality of life of patients with advanced cancer
29. Health‐related quality of life measurement for evaluation research and policy analysis
30. Overview: Assessment of quality of life in clinical trials of cardiovascular therapies
31. State of science 1986: Quality of life and functional status as target variables for research
32. Standards for validating health measures: Definitions and content
33. Measuring the quality of life of cancer patients: Psychometric properties of instruments
34. Conceptualizing disease impact and treatment outcomes
35. Scientific and clinical problems in indexes of functional disability
36. Measuring and analyzing quality of life in cancer clinical trials: A review
37. Measuring the quality of life of patients with cancer
38. Quantitative issues in health‐related quality of life assessment
39. Measuring quality of life in clinical trials: A taxonomy and review
40. Evaluation of quality of life in patients receiving treatment for advanced breast cancer
41. Quality of life in stage II breast cancer: An instrument for clinical trials
42. Measuring the quality of life of cancer patients: The Functional Living Index—Cancer
43. Quality of life index for patients with cancer
44. Measuring the quality of life of cancer patients: A concise QL‐Index for use by physicians
45. The development of a method of assessing the quality of life for cancer patients
46. A modular approach to quality of life assessment in cancer clinical trials
47. Measuring and analyzing quality of life in cancer clinical trials: A review
48. Quality of life end points in cancer clinical trials: Review and recommendations
49. Measuring quality of life in cancer patients
50. The Sickness Impact Profile: Development and final revision of a health status measure
51. The Nottingham Health Profile: Subjective health status and medical consultations
52. Classifying function for health outcome and quality of life evaluation: Self versus individual models
53. The MOS Short‐form General Health Survey
54. Methodological issues in psychosocial oncology with special reference to clinical trials
55. The science of quality of life
56. Practical problems in conducting cancer‐related psychosocial research
57. Cancer patients: Knowledge and attitudes
58. Do psychological studies upset patients?
59. Prospects and problems in European psychosocial oncology: A survey of the EORTC Study Group on Quality of Life
60. Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Function Living Index—Cancer
61. Quality‐of‐life assessment of cancer patients: Conceptual and methodological challenges and constraints